453 filings
Page 16 of 23
6-K
CLLS
Cellectis
13 Feb 18
Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells
12:00am
SC 13G/A
CLLS
Cellectis
13 Feb 18
Cellectis S.A.
12:00am
6-K
CLLS
Cellectis
9 Jan 18
Current report (foreign)
12:00am
S-8
CLLS
Cellectis
9 Jan 18
Registration of securities for employees
12:00am
6-K
CLLS
Cellectis
13 Dec 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
4 Dec 17
Cellectis Appoints Elsy Boglioli to Executive Vice President, Strategy and Corporate Development
12:00am
6-K
CLLS
Cellectis
4 Dec 17
Cellectis Appoints Immuno-Oncology Leader Stéphane Depil to Position of Senior Vice President Research & Development and Chief Medical Officer
12:00am
UPLOAD
CLLS
Cellectis
28 Nov 17
Letter from SEC
12:00am
6-K
CLLS
Cellectis
20 Nov 17
Cellectis Demonstrates Fine and Predictable Tuning of TALEN® Gene Editing Targeting to Improve T-cell Adoptive Immunotherapy
12:00am
CORRESP
CLLS
Cellectis
14 Nov 17
Correspondence with SEC
12:00am
6-K
CLLS
Cellectis
13 Nov 17
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
13 Nov 17
Cellectis Reports Financial Results for Third Quarter and First Nine Months of 2017
12:00am
6-K
CLLS
Cellectis
7 Nov 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
3 Nov 17
Cellectis Announces Two Oral Presentations and One Poster Presentation at the 2017 ASH Annual Meeting
12:00am
6-K
CLLS
Cellectis
1 Nov 17
Cellectis S.a. 6-K
12:00am
UPLOAD
CLLS
Cellectis
31 Oct 17
Letter from SEC
12:00am
CORRESP
CLLS
Cellectis
10 Oct 17
Correspondence with SEC
12:00am
6-K
CLLS
Cellectis
4 Oct 17
Cellectis S.a. 6-K
12:00am
CORRESP
CLLS
Cellectis
25 Sep 17
Correspondence with SEC
12:00am
UPLOAD
CLLS
Cellectis
12 Sep 17
Letter from SEC
12:00am